| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Canertinib |
Canertinib (CI-1033游離) |
267243-28-7 |
詳細
|
| Ataluren |
阿塔魯倫 |
775304-57-9 |
詳細
|
| Canagliflozin |
卡格列凈 |
842133-18-0 |
詳細
|
| CNX-77 |
CNX-774 |
1202759-32-7 |
詳細
|
| Cabotegravir (GSK744, GSK1265744) |
卡博特韋 |
1051375-10-0 |
詳細
|
| ONO-4059 |
替拉魯替尼 |
1351636-18-4 |
詳細
|
| Grapiprant |
GRAPIPRANT |
415903-37-6 |
詳細
|
| Roscovitine (CYC202,Seliciclib) |
細胞周期蛋白B激酶抑制劑 |
186692-46-6 |
詳細
|
| Clemastine fumarate |
富馬酸氯馬斯汀 |
14976-57-9 |
詳細
|
| Ramelteon |
雷美替胺 |
196597-26-9 |
詳細
|
| (+)-Tetrabenazine |
(3R,11BR)-1,3,4,6,7,11B-六氫-9,10-二甲氧基-3-異丁基-2H-苯并[A]喹嗪-2-酮 |
1026016-83-0 |
詳細
|
| PF-06840003 |
3-(5-氟-1H-吲哚-3-基)-2,5-吡咯烷二酮 |
198474-05-4 |
詳細
|
| Varlitinib |
泛EGFR小分子抑制劑(VARLITINIB) |
845272-21-1 |
詳細
|
| MS436 |
(E)-4-((2-AMINO-4-HYDROXY-5-METHYLPHENYL)DIAZENYL)-N-(PYRIDIN-2-YL)BENZENESULFONAMIDE |
1395084-25-9 |
詳細
|
| BAY-1217389 |
CS-2361 |
1554458-53-5 |
詳細
|
| lusutrombopag |
魯索曲波帕 |
1110766-97-6 |
詳細
|
| (2R)-14-fluoro-2-methyl-6,9,10,19-tetraazapentacyclo[14.2.1.02,.0,1.012,1]nonadeca-1(18),8,12(17),13,15-pentaen-11-one |
帕米帕利 |
1446261-44-4 |
詳細
|
| TAK-931 |
TAK 931 |
1330782-76-7 |
詳細
|
| Alvocidib hydrochloride |
(-)-2-(2-氯苯基)-5,7-二羥基-8-[(3S,4R)-3-羥基-1-甲基-4-哌啶基]-4H-1-苯并吡喃-4-酮鹽酸鹽 |
131740-09-5 |
詳細
|
| Prucalopride |
普卡必利 |
179474-81-8 |
詳細
|
| LDN 193189 |
LDN-193189 |
1062368-24-4 |
詳細
|
| SB-705498 |
SB-705498 |
501951-42-4 |
詳細
|
| Rociletinib |
CO1686 |
1374640-70-6 |
詳細
|
| Mirogabalin |
米洛巴林 |
1138245-13-2 |
詳細
|
| SAR-20347 |
CPDD1211 |
1450881-55-6 |
詳細
|
| KPT-8602 |
CS-2388 |
1642300-52-4 |
詳細
|
| 3-(3,4-Dihydroxyphenyl)-L-alanine |
左旋多巴 |
59-92-7 |
詳細
|
| Entinostat (MS-275, SNDX-275) |
恩替諾特 |
209783-80-2 |
詳細
|
| Rolipram |
諾普利蘭 |
61413-54-5 |
詳細
|
| PRT 062607 |
化合物 T24584 |
1370261-98-5 |
詳細
|
| N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide |
N-(4-氯-3-吡啶基)-4-[(2,2-二氟-1,3-苯并二惡茂-5-基)甲基]-1-哌嗪甲酰胺 |
1346528-50-4 |
詳細
|
| Canagliflozin hemihydrate |
卡格列凈半水合物 |
928672-86-0 |
詳細
|
| azd-8186 |
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-嗎啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 |
1627494-13-6 |
詳細
|
| CC-223 |
CC-223 |
1228013-30-6 |
詳細
|
| Solifenacin succinate |
索利那新琥珀酸鹽 |
242478-38-2 |
詳細
|
| Prednisolone |
潑尼松龍 |
50-24-8 |
詳細
|
| SGX523 |
SGX-523 |
1022150-57-7 |
詳細
|
| GNF-7 |
GNF-7 |
839706-07-9 |
詳細
|
| CUDC-907 |
CUDC-907 |
1339928-25-4 |
詳細
|
| TAK-385 |
Relugolix游離態(tài) |
737789-87-6 |
詳細
|
| R 7090 Basim lurant CTEP Derivative |
BASIMGLURANT |
802906-73-6 |
詳細
|
| Ozanimod |
奧扎莫德 |
1306760-87-1 |
詳細
|
| 2-Hydroxyflutamide |
羥基氟他胺 |
52806-53-8 |
詳細
|
| mk-1064 |
MK-1064 |
1207253-08-4 |
詳細
|
| Mozavaptan |
莫扎伐普坦 |
137975-06-5 |
詳細
|
| Apixaban |
阿哌沙班 |
503612-47-3 |
詳細
|
| Odanacatib |
(2S)-N-(1-氰基環(huán)丙基)-4-氟-4-甲基-2-[[(1S)-2,2,2-三氟-1-[4'-(甲基磺?；?[1,1'-聯(lián)苯]-4-基]乙基]氨基]戊酰胺 |
603139-19-1 |
詳細
|
| Gandotinib |
LY 2784544 |
1229236-86-5 |
詳細
|
| β-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)- |
索格列凈 |
1018899-04-1 |
詳細
|
| APR-246 |
APR-246 |
5291-32-7 |
詳細
|
| Benzo[h]-1,6-naphthyridin-2(1H)-one, 9-(6-amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]- |
9-(6-氨基-3-吡啶基)-1-[3-(三氟甲基)苯基]苯并[H]-1,6-萘啶-2(1H)-酮 |
1223001-51-1 |
詳細
|
| RVX-208 |
RVX-208 |
1044870-39-4 |
詳細
|
| Cebranopadol |
CEBRANOPADOL |
863513-91-1 |
詳細
|
| Glycine ethyl ester hydrochloride |
甘氨酸乙酯鹽酸鹽 |
623-33-6 |
詳細
|
| AQW-051 |
AQW-051 |
669770-29-0 |
詳細
|
| LOXO-101 |
拉羅替尼 |
1223403-58-4 |
詳細
|
| 4-ethyl-N-{3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl}-3-(2-{pyrazolo[1,5-a]pyrimidin-6-yl}ethynyl)benzamide |
DDR1-IN-2 |
1429617-90-2 |
詳細
|
| JNJ-42847922 |
JNJ-42847922 |
1293281-49-8 |
詳細
|
| (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide |
辣椒堿 |
404-86-4 |
詳細
|
| Riociguat |
利奧西呱 |
625115-55-1 |
詳細
|
| Lumateperone |
盧美哌隆 |
313368-91-1 |
詳細
|
| XMU-MP-1 |
XMU-MP-1 |
2061980-01-4 |
詳細
|
| MK-2206 2HCl |
8-[4-(1-氨基環(huán)丁基)苯基]-9-苯基-1,2,4-三唑并[3,4-f][1,6]萘啶-3(2H)-酮二鹽酸鹽 |
1032350-13-2 |
詳細
|
| Indacaterol |
馬來酸茚達特羅 |
753498-25-8 |
詳細
|
| Vortioxetine hydrobromide |
氫溴酸沃替西汀 |
960203-27-4 |
詳細
|
| SAR-260093 |
5-乙基-2-[4-[4-[[[4-(1H-四氮唑-1-基)苯基]氧基]甲基]噻唑-2-基]哌啶-1-基]嘧啶 |
1037792-44-1 |
詳細
|
| 2-chloro-4-[2-[2,5-dimethyl-1-[4-(trifluoromethoxy)phenyl]imidazol-4-yl]ethynyl]pyridine |
MGluR5 inhibitor |
871362-31-1 |
詳細
|
| 2-(4-Acetamido-3-((4-chlorophenyl)thio)-2-methyl-1H-indol-1-yl)acetic acid |
AZD1981 |
802904-66-1 |
詳細
|
| ly-3009120 |
LY-3009120 |
1454682-72-4 |
詳細
|
| (Z)-4-amino-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide |
4-氨基-N-(3-溴-4-氟苯基)-N'-羥基-1,2,5-惡二唑-3-甲脒 |
914638-30-5 |
詳細
|
| Hemoglobin Modulators-1 |
沃塞洛托 |
1446321-46-5 |
詳細
|
| ON123300 |
8-環(huán)戊基-7,8-二氫-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
詳細
|
| MMV-390048 |
化合物MMV390048 |
1314883-11-8 |
詳細
|
| CYR-101 |
MIN-101 |
359625-79-9 |
詳細
|
| e-6005 |
E6005 |
947620-48-6 |
詳細
|
| diindolylmethane |
3,3'-二吲哚甲烷 |
1968-05-4 |
詳細
|
| (7R)-2-(4-phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide |
(R)-贊魯替尼 |
1691249-44-1 |
詳細
|
| 6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide |
BMS-986165 |
1609392-27-9 |
詳細
|
| Benzoic acid, 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]- |
地拉羅司 |
201530-41-8 |
詳細
|
| Aclidinium bromide |
阿地溴銨 |
320345-99-1 |
詳細
|
| Atipamezole |
阿替美唑 |
104054-27-5 |
詳細
|
| (betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile phosphate |
魯索利替尼磷酸鹽 |
1092939-17-7 |
詳細
|
| PF-04447943 |
PF 4447943 |
1082744-20-4 |
詳細
|
| Propanoic acid, 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-, 1-methylethylester |
非諾貝特 |
49562-28-9 |
詳細
|
| BLU 9931 |
BLU 9931 |
1538604-68-0 |
詳細
|
| 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoic acid |
塞曲司特 |
112665-43-7 |
詳細
|
| Gemigliptin;(2R,3R)-2,3-dihydroxybutanedioic acid |
吉格列汀酒石酸鹽 |
1374639-74-3 |
詳細
|
| PD168393 |
PD168393 |
194423-15-9 |
詳細
|
| Dapagliflozin |
達格列凈 |
461432-26-8 |
詳細
|
| LX-1606 Hippurate |
特羅司他乙酯 |
1033805-22-9 |
詳細
|
| 1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)- |
3-(2-氨基-5-苯并惡唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 |
1224844-38-5 |
詳細
|
| GS-9620 |
GS9620 |
1228585-88-3 |
詳細
|
| 2-Pyridineacetamide, N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]- |
CB-839 |
1439399-58-2 |
詳細
|
| Lifitegrast |
立他司特 |
1025967-78-5 |
詳細
|
| Erlotinib |
埃羅替尼 |
183321-74-6 |
詳細
|
| (7S)-2-(4-phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide |
澤布替尼 |
1691249-45-2 |
詳細
|
| Tamoxifen |
他莫昔芬 |
10540-29-1 |
詳細
|
| PF-06700841 |
CS-2861 |
1883299-62-4 |
詳細
|
| PF 06700841-15 |
CS-2860 |
2140301-96-6 |
詳細
|
| 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione |
SB216763 |
280744-09-4 |
詳細
|